Technical Analysis for PETQ - PetIQ, Inc.

Grade Last Price % Change Price Change
grade B 35.655 -0.96% -0.35
PETQ closed up 1.35 percent on Friday, July 19, 2019, on 59 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Earnings due: Aug 7

*** please verify all earnings dates ***
2 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical PETQ trend table...

Date Alert Name Type % Chg
Overbought Stochastic Strength -0.96%
Overbought Stochastic Strength 0.38%
Overbought Stochastic Strength -0.27%
Up 3 Days in a Row Strength -0.27%
Up 4 Days in a Row Strength -0.27%
Narrow Range Bar Range Contraction 0.41%
NR7 Range Contraction 0.41%
Overbought Stochastic Strength 0.41%
Up 3 Days in a Row Strength 0.41%
Golden Cross Bullish 1.18%

Older signals for PETQ ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators
Basic chart:
Profile
PetIQ, Inc. is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield. It distributes the products through veterinarian, retail and e-commerce channels. The Company offers its products in a range of categories, including Rx Medications, OTC Medications and Supplies, and Health and Wellness Products. Rx Medications offering includes heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics and other specialty medications. The Company manufactures Heart Shield Plus, version of Heartgard Plus, which prevents heartworm infection in dogs. The Company also manufactures TruProfen, the version of Rimadyl, which treats arthritis in dogs. OTC Medications and Supplies include flea and tick control products.
Manufacturing Retail Stores Pain Diabetes Control Products Antibiotics Arthritis Wellness Products E Commerce Channels Zoonoses Dirofilaria Immitis Rimadyl Wellness
Is PETQ a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Jul 19 Should You Be Concerned About PetIQ, Inc.'s (NASDAQ:PETQ) ROE?
Jul 17 PetIQ, Inc. to Report Second Quarter 2019 Results on Wednesday, August 7th
Jul 9 INVESTIGATION REMINDER for VRNT, PETQ, CTSH and PT: Hagens Berman Reminds Investors of Ongoing Investigations
Jul 8 Perrigo Completes Divestiture of Animal Health Business for $185 Million
Jul 8 PetIQ, Inc. Completes Acquisition of Perrigo Animal Health
Jul 3 Perrigo Completes Ranir Acquisition, Raises '19 Guidance
Jun 27 Bragar Eagel & Squire, P.C. is Investigating Acer Therapeutics, Diebold Nixdorf, Sunlands Technology Group, and PetIQ and Encourages Investors to Contact the Firm
Jun 26 Here’s What Hedge Funds Think About Stagnant On PetIQ, Inc. (PETQ)
Jun 20 How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks
Jun 20 INVESTIGATION ALERT FOR CTSH, PETQ, AND EROS: Hagens Berman Alerts Investors in CTSH, PETQ, and EROS to the Firm’s Investigation of Potential Disclosure Violations, Encourages Investors to Contact the Firm
See more PETQ news...
Indicators
Indicator Value
52 Week High 43.93
52 Week Low 21.29
Average Volume 374,361
200-Day Moving Average 29.8567
50-Day Moving Average 30.655
20-Day Moving Average 33.6925
10-Day Moving Average 34.895
Average True Range 1.0947
ADX 35.38
+DI 31.9515
-DI 11.0423
Chandelier Exit (Long, 3 ATRs ) 32.9459
Chandelier Exit (Short, 3 ATRs ) 32.6341
Upper Bollinger Band 37.294
Lower Bollinger Band 30.091
Percent B (%b) 0.82
BandWidth 21.378645
MACD Line 1.4726
MACD Signal Line 1.4095
MACD Histogram 0.0631
Fundamentals Value
Market Cap 476.03 Million
Num Shares 13.2 Million
EPS 0.50
Price-to-Earnings (P/E) Ratio 72.00
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 37.19
Resistance 3 (R3) 37.14 36.68 37.00
Resistance 2 (R2) 36.68 36.38 36.71 36.93
Resistance 1 (R1) 36.34 36.19 36.51 36.40 36.86
Pivot Point 35.89 35.89 35.97 35.92 35.89
Support 1 (S1) 35.55 35.58 35.72 35.60 35.14
Support 2 (S2) 35.09 35.40 35.12 35.07
Support 3 (S3) 34.75 35.09 35.00
Support 4 (S4) 34.81